Guohui Xu
Guohui Xu
Explore linked clinical trials.1 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| TACE Plus Camrelizumab and Apatinib for Unresectable Hepatocellular Carcinoma | Apatinib; Camrelizumab; Transarterial Chemoembolization; Unresectable Hepatocellular Carcinoma | Recruiting | Phase 3 | 2026-04-14 | NCT06485466 |